These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23857024)

  • 1. Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama.
    Sosa N; Capitán Z; Nieto J; Nieto M; Calzada J; Paz H; Spadafora C; Kreishman-Deitrick M; Kopydlowski K; Ullman D; McCarthy WF; Ransom J; Berman J; Scott C; Grogl M
    Am J Trop Med Hyg; 2013 Sep; 89(3):557-563. PubMed ID: 23857024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
    Ben Salah A; Ben Messaoud N; Guedri E; Zaatour A; Ben Alaya N; Bettaieb J; Gharbi A; Belhadj Hamida N; Boukthir A; Chlif S; Abdelhamid K; El Ahmadi Z; Louzir H; Mokni M; Morizot G; Buffet P; Smith PL; Kopydlowski KM; Kreishman-Deitrick M; Smith KS; Nielsen CJ; Ullman DR; Norwood JA; Thorne GD; McCarthy WF; Adams RC; Rice RM; Tang D; Berman J; Ransom J; Magill AJ; Grogl M
    N Engl J Med; 2013 Feb; 368(6):524-32. PubMed ID: 23388004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical paromomycin for New World cutaneous leishmaniasis.
    Sosa N; Pascale JM; Jiménez AI; Norwood JA; Kreishman-Detrick M; Weina PJ; Lawrence K; McCarthy WF; Adams RC; Scott C; Ransom J; Tang D; Grogl M
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007253. PubMed ID: 31048871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis.
    Ravis WR; Llanos-Cuentas A; Sosa N; Kreishman-Deitrick M; Kopydlowski KM; Nielsen C; Smith KS; Smith PL; Ransom JH; Lin YJ; Grogl M
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4809-15. PubMed ID: 23877689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M; Schuster BG; Ellis WY; Berman JD
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical paromomycin and gentamicin for new world cutaneous leishmaniasis in Panama.
    Monge-Maillo B; López-Vélez R
    Am J Trop Med Hyg; 2014 Jun; 90(6):1191. PubMed ID: 24898981
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
    Soto J; Fuya P; Herrera R; Berman J
    Clin Infect Dis; 1998 Jan; 26(1):56-8. PubMed ID: 9455509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
    Arana BA; Mendoza CE; Rizzo NR; Kroeger A
    Am J Trop Med Hyg; 2001 Nov; 65(5):466-70. PubMed ID: 11716099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.
    Neva FA; Ponce C; Ponce E; Kreutzer R; Modabber F; Olliaro P
    Trans R Soc Trop Med Hyg; 1997; 91(4):473-5. PubMed ID: 9373659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
    Soto J; Soto P; Ajata A; Luque C; Tintaya C; Paz D; Rivero D; Berman J
    Clin Infect Dis; 2019 Feb; 68(5):844-849. PubMed ID: 30260376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.
    Iraji F; Sadeghinia A
    Ann Trop Med Parasitol; 2005 Jan; 99(1):3-9. PubMed ID: 15701249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
    Faghihi G; Tavakoli-kia R
    Clin Exp Dermatol; 2003 Jan; 28(1):13-6. PubMed ID: 12558620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX; Weigel MM; Calvopiña M; Mancheno M; Rodriguez R
    Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
    Soto J; Hernandez N; Mejia H; Grogl M; Berman J
    Clin Infect Dis; 1995 Jan; 20(1):47-51. PubMed ID: 7727669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.
    Ben Salah A; Zakraoui H; Zaatour A; Ftaiti A; Zaafouri B; Garraoui A; Olliaro PL; Dellagi K; Ben Ismail R
    Am J Trop Med Hyg; 1995 Aug; 53(2):162-6. PubMed ID: 7677218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.
    Asilian A; Jalayer T; Whitworth JA; Ghasemi RL; Nilforooshzadeh M; Olliaro P
    Am J Trop Med Hyg; 1995 Dec; 53(6):648-51. PubMed ID: 8561269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
    Schallreuter KU; Lemke KR
    Hautarzt; 1994 Nov; 45(11):783-6. PubMed ID: 7822205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.
    Ben Salah A; Buffet PA; Morizot G; Ben Massoud N; Zâatour A; Ben Alaya N; Haj Hamida NB; El Ahmadi Z; Downs MT; Smith PL; Dellagi K; Grögl M
    PLoS Negl Trop Dis; 2009; 3(5):e432. PubMed ID: 19415122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
    Asilian A; Davami M
    Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
    Weinrauch L; Cawich F; Craig P; Sosa JX; el-On J
    J Am Acad Dermatol; 1993 Sep; 29(3):443-6. PubMed ID: 8349861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.